| 1 |
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 , OPRM1 , and COMT Genotypes and Select Opioid Therapy
Kristine R. Crews et al. · Clinical Pharmacology & Therapeutics
Open access |
2 Jan 2021 |
427 |
| 2 |
Combining fMRI and SNP data to investigate connections between brain function and genetics using parallel ICA
Jingyu Liu, Godfrey D. Pearlson, Andreas Windemuth et al. · Human Brain Mapping
Open access |
10 Dec 2007 |
280 |
| 3 |
Multivariate analysis reveals genetic associations of the resting default mode network in psychotic bipolar disorder and schizophrenia
Shashwath A. Meda, Gualberto Ruaño, Andreas Windemuth et al. · Proceedings of the National Academy of Sciences
Open access |
28 Apr 2014 |
261 |
| 4 |
PharmVar GeneFocus: CYP2D6
Charity Nofziger, Amy Jane Turner, Katrin Sangkuhl et al. · Clinical Pharmacology & Therapeutics
Open access |
23 Sep 2019 |
254 |
| 5 |
A clinical study of the association of antipsychotics with hyperlipidemia
José de León, Margaret T. Susce, Maria S. Johnson et al. · Schizophrenia Research
|
9 Mar 2007 |
77 |
| 6 |
Pharmacogenetic Testing in Psychiatry: A Review of Features and Clinical Realities
José de León, Maria Jesús Arranz, Gualberto Ruaño · Clinics in Laboratory Medicine
|
Dec 2008 |
74 |
| 7 |
Physiogenomic association of statin‐related myalgia to serotonin receptors
Gualberto Ruaño, Paul D. Thompson, Andreas Windemuth et al. · Muscle & Nerve
|
28 Jun 2007 |
73 |
| 8 |
New and confirmatory evidence of an association between APOE genotype and baseline C-reactive protein in dyslipidemic individuals
Richard Judson, Carlos W. Brain, Brad Dain et al. · Atherosclerosis
|
10 Sep 2004 |
65 |
| 9 |
Mechanisms of statin-induced myalgia assessed by physiogenomic associations
Gualberto Ruaño, Andreas Windemuth, Alan H.B. Wu et al. · Atherosclerosis
Open access |
24 Jul 2011 |
64 |
| 10 |
Physiogenomic comparison of weight profiles of olanzapine- and risperidone-treated patients
Gualberto Ruaño, John W. Goethe, Charles F. Caley et al. · Molecular Psychiatry
|
2 Jan 2007 |
62 |
| 11 |
Genetic Associations of Brain Structural Networks in Schizophrenia: A Preliminary Study
Kanchana Jagannathan, Vince D. Calhoun, Joel E. Gelernter et al. · Biological Psychiatry
Open access |
6 Aug 2010 |
56 |
| 12 |
Length of Psychiatric Hospitalization is Correlated With CYP2D6 Functional Status in Inpatients with Major Depressive Disorder
Gualberto Ruaño, Bonnie L. Szarek, David Villagra et al. · Biomarkers in Medicine
Open access |
Jun 2013 |
47 |
| 13 |
Exploring genetic variations that may be associated with the direct effects of some antipsychotics on lipid levels
José de León, Juan Carlos Correa, Gualberto Ruaño et al. · Schizophrenia Research
|
Dec 2007 |
45 |
| 14 |
Ethnogeographic Prevalence and Implications of the 677C>T and 1298A>C MTHFR Polymorphisms in Us Primary Care Populations
James S. Graydon, Karla Claudio, Seth H. Baker et al. · Biomarkers in Medicine
Open access |
Jun 2019 |
44 |
| 15 |
Physiogenomic Analysis Links Serum Creatine Kinase Activities During Statin Therapy to Vascular Smooth Muscle Homeostasis
Gualberto Ruaño, Paul Daniel Thompson, Andreas Windemuth et al. · Pharmacogenomics
|
21 Nov 2005 |
44 |
| 16 |
Multivariate genetic determinants of EEG oscillations in schizophrenia and psychotic bipolar disorder from the BSNIP study
Balaji Narayanan, Pauline Soh, Vince D. Calhoun et al. · Translational Psychiatry
Open access |
23 Jun 2015 |
43 |
| 17 |
Apolipoprotein A1 genotype affects the change in high density lipoprotein cholesterol subfractions with exercise training
Gualberto Ruaño, Richard L. Seip, Andreas Windemuth et al. · Atherosclerosis
Open access |
12 Jul 2005 |
41 |
| 18 |
Quo vadis personalized medicine?
Gualberto Ruaño · Personalized Medicine
|
Dec 2004 |
39 |
| 19 |
A Novel Admixture-Based Pharmacogenetic Approach to Refine Warfarin Dosing in Caribbean Hispanics
Jorge Duconge-Soler, Alga S Ramos, Karla Claudio‐Campos et al. · PLoS ONE
Open access |
8 Jan 2016 |
36 |
| 20 |
Retrospective validation of genomic biomarkers – what are the questions, challenges and strategies for developing useful relationships to clinical outcomes – workshop summary
S-J Wang, Nadine Cohen, David A. Katz et al. · The Pharmacogenomics Journal
|
10 Jan 2006 |
32 |
| 21 |
Physiogenomic Analysis of the Puerto Rican Population
Gualberto Ruaño, Jorge Duconge-Soler, Andreas Windemuth et al. · Pharmacogenomics
Open access |
Apr 2009 |
31 |
| 22 |
Physiogenomic analysis of weight loss induced by dietary carbohydrate restriction
Gualberto Ruaño, Andreas Windemuth, Mohan Kocherla et al. · Nutrition & Metabolism
Open access |
15 May 2006 |
31 |
| 23 |
Novel Drug Metabolism Indices for Pharmacogenetic Functional Status Based on Combinatory Genotyping of CYP2C9 , CYP2C19 and CYP2D6 Genes
David Villagra, John W. Goethe, Harold I. Schwartz et al. · Biomarkers in Medicine
Open access |
Aug 2011 |
29 |
| 24 |
Pharmacogenomic Data Submissions to the FDA: Clinical Pharmacology Case Studies
Gualberto Ruaño, Jerry M. Collins, Andrew J. Dorner et al. · Pharmacogenomics
|
Jul 2004 |
29 |
| 25 |
Implementing genotype-guided Antithrombotic Therapy
Richard L. Seip, Jorge Duconge-Soler, Gualberto Ruaño · Future Cardiology
Open access |
May 2010 |
28 |
| 26 |
Development of a Pharmacogenetic-Guided Warfarin Dosing Algorithm for Puerto Rican Patients
Alga S Ramos, Richard L. Seip, Giselle C Rivera-Miranda et al. · Pharmacogenomics
Open access |
Dec 2012 |
28 |
| 27 |
Physiogenomic comparison of edema and BMI in patients receiving rosiglitazone or pioglitazone
Gualberto Ruaño, James L Bernene, Andreas Windemuth et al. · Clinica Chimica Acta
|
27 Oct 2008 |
27 |
| 28 |
Results of the CYP-GUIDES randomized controlled trial: Total cohort and primary endpoints
Gualberto Ruaño, Saskia Robinson, Theodore R. Holford et al. · Contemporary Clinical Trials
|
12 Dec 2019 |
25 |
| 29 |
CYP2C9 and VKORC1 genotypes in Puerto Ricans: A case for admixture-matching in clinical pharmacogenetic studies
David Villagra, Jorge Duconge-Soler, Andreas Windemuth et al. · Clinica Chimica Acta
Open access |
20 May 2010 |
24 |
| 30 |
Physiogenomic Analysis of Localized fMRI Brain Activity in Schizophrenia
Andreas Windemuth, Vince D. Calhoun, Godfrey D. Pearlson et al. · Annals of Biomedical Engineering
Open access |
10 Mar 2008 |
23 |
| 31 |
Physiogenomic Analysis of CYP450 Drug Metabolism Correlates Dyslipidemia With Pharmacogenetic Functional Status in Psychiatric Patients
Gualberto Ruaño, David Villagra, Bonnie L. Szarek et al. · Biomarkers in Medicine
Open access |
Aug 2011 |
22 |
| 32 |
Fundamental Considerations for Genetically-Guided Pain Management with Opioids Based on CYP2D6 and OPRM1 Polymorphisms.
Gualberto Ruaño, Jonathan A Kost · PubMed
|
Nov 2018 |
21 |
| 33 |
Isolation of Microsporum gypseum in soil samples from different geographical regions of Brazil, evaluation of the extracellular proteolytic enzymes activities (keratinase and elastase) and molecular sequencing of selected strains
Mauro Cintra Giudice, Adriana Araújo Reis-Menezes, Glauce Mary Gomes Rittner et al. · Brazilian Journal of Microbiology
Open access |
Sep 2012 |
21 |
| 34 |
Warfarin Anticoagulation Therapy in Caribbean Hispanics of Puerto Rico: A Candidate Gene Association Study
Karla Claudio‐Campos, Aurora Labastida, Alga S Ramos et al. · Frontiers in Pharmacology
Open access |
7 Jun 2017 |
20 |
| 35 |
Prediction of Warfarin Dose Reductions in Puerto Rican Patients, Based on Combinatorial CYP2C9 and VKORCI Genotypes
Isa Ivette Valentin, Joan Vazquez, Giselle C Rivera-Miranda et al. · Annals of Pharmacotherapy
Open access |
24 Jan 2012 |
19 |
| 36 |
Physiogenomic comparison of human fat loss in response to diets restrictive of carbohydrate or fat
Richard L. Seip, Jeff S. Volek, Andreas Windemuth et al. · Nutrition & Metabolism
Open access |
6 Feb 2008 |
19 |
| 37 |
Acetyl-coenzyme A carboxylase α gene variations may be associated with the direct effects of some antipsychotics on triglyceride levels
Francisco J. Díaz, Alexander Meary, Maria Jesús Arranz et al. · Schizophrenia Research
Open access |
28 Oct 2009 |
18 |
| 38 |
VEGFA GENE variation influences hallucinations and frontotemporal morphology in psychotic disorders: a B-SNIP study
Paulo L. Lizano, Olivia Lutz, George M. Ling et al. · Translational Psychiatry
Open access |
11 Oct 2018 |
16 |
| 39 |
Pharmacogenetic Testing for Analgesic Adverse Effects
Renee C.B. Manworren, Lauren Jeffries, Ashley Pantaleao et al. · Clinical Journal of Pain
|
24 Mar 2015 |
15 |
| 40 |
Practical interpretation of CYP2D6 haplotypes: Comparison and integration of automated and expert calling
Gualberto Ruaño, Mohan Kocherla, James S. Graydon et al. · Clinica Chimica Acta
|
20 Feb 2016 |
14 |
| 41 |
High Carrier Prevalence of Deficient and Null Alleles of CYP2 Genes in a Major USA Hospital: Implications for Personalized Drug Safety
Gualberto Ruaño, Greg Makowski, Andreas Windemuth et al. · Personalized Medicine
|
May 2006 |
14 |
| 42 |
Increased Carrier Prevalence Of Deficient Cyp2C9 , Cyp2C19 and Cyp2D6 Alleles in Depressed Patients Referred to a Tertiary Psychiatric Hospital
Gualberto Ruaño, David Villagra, Umme Salma Rahim et al. · Personalized Medicine
|
Nov 2008 |
13 |
| 43 |
Assessment of the clinical utility of pharmacogenetic guidance in a comprehensive medication management service
Idaliz Rodríguez‐Escudero, Julio A. Cedeño, Ileana Rodríguez‐Nazario et al. · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY
Open access |
2 May 2020 |
11 |
| 44 |
Novel gene-brain structure relationships in psychotic disorder revealed using parallel independent component analyses
Neeraj Tandon, Pranav Nanda, Jaya L. Padmanabhan et al. · Schizophrenia Research
|
24 Oct 2016 |
11 |
| 45 |
Multivariate Genetic Correlates of the Auditory Paired Stimuli-Based P2 Event-Related Potential in the Psychosis Dimension From the BSNIP Study
Mohammadreza Mokhtari, Balaji Narayanan, Jordan P. Hamm et al. · Schizophrenia Bulletin
Open access |
12 Oct 2015 |
11 |
| 46 |
Guidance of pharmacotherapy in a complex psychiatric case by CYP450 DNA typing
Joan Landino, Jane Buckley, John M. Roy et al. · Journal of the American Academy of Nurse Practitioners
|
25 Jul 2011 |
11 |
| 47 |
Physiogenomic Analysis of Statin-Treated Patients: Domain-Specific Counter Effects within the ACACB Gene on Low-Density Lipoprotein Cholesterol?
Gualberto Ruaño, Paul Daniel Thompson, John P. Kane et al. · Pharmacogenomics
Open access |
Jul 2010 |
10 |
| 48 |
High Carrier Prevalence of Combinatorial CYP2C9 and VKORC1 Genotypes Affecting Warfarin Dosing
Gualberto Ruaño, Paul D Thompson, David Villagra et al. · Personalized Medicine
|
May 2008 |
10 |
| 49 |
Somatic complications of psychotropic medications in a patient with multiple CYP2 drug metabolism deficiencies.
Gualberto Ruaño, Catherine Blair, Bruce Bower et al. · PubMed
|
Apr 2007 |
8 |
| 50 |
A novel approach to analyzing fMRI and SNP data via parallel independent component analysis
Jingyu Liu, Godfrey D. Pearlson, Vince D. Calhoun et al. · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE
Conference paper |
8 Mar 2007 |
7 |